Biomira About
Biomira: Biomira Inc. is a biotechnology company applying
its leading technology in immunotherapy and organic chemistry for the development
of cancer therapeutics. The Company's commitment to the development of products
for the treatment of cancer is currently focused on synthetic therapeutic vaccines
and innovative strategies for immunotherapeutic treatment of cancer. The
liposome - based vaccine technology being developed by Biomira is a completely
synthetic composition of antigen, adjuvants and lipomatrix. Biomira also believes
that the liposomal vaccine technology platform may be equally applicable to infectious
disease antigens, particularly for chronic diseases such as tuberculosis, malaria
and hepatitis. Pipeline
info Biomira -- Clinical Trials More
on Biomira:
Key
Statistics for Biomira
Theratope
Vaccine Colorectal
BLP25
Liposome Vaccine Prostate BLP25
Liposome Vaccine Non-small
cell lung cancer
Basic
Chart for Biomira